Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Sodium Bicarbonate Injection
Status: Currently in Shortage
»Date first posted:
03/01/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric
Amphastar Pharmaceuticals, Inc./IMS (Reverified 01/05/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Sodium Bicarbonate Inj. USP, 8.4%, 50mL Luer-Jet Prefilled Syringe, (NDC 0548-3352-00), (new NDC 76329-3352-1) | Backorder due to the increase in demands | Demand increase for the drug |
Exela Pharma Sciences, LLC (Revised 01/31/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 8.4%, 50mL (NDC 51754-5001-05) | Available | Demand increase for the drug | |
| 10 mEq/10 mL (NDC 2551754-5011-04) | Currently on backorder | ||
| 5 mEq/10 mL, 4.2%, (NDC 51754-5012-04) | On backorder |
Fresenius Kabi USA, LLC (Reverified 03/10/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 4.2% Single dose vial, 2.5 mEq per 5 mL (0.5 mEq per mL) (42 mg per mL)(NDC 63323-083-05) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 8.4% Single dose vial, 50 mEq per 50 mL (1 mEq per mL) (84 mg per mL)(NDC 63323-089-50) | Backordered. Next release March 2023. | Check wholesalers for inventory | Demand increase for the drug |
Hospira, Inc., a Pfizer company (Revised 03/17/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Infant 5 mEq/10 mL (0.5 mEq/mL) ABBOJECT® Glass Syringe (4.2% Concentration) (NDC 0409-5534-14) (old NDC 0409-5534-34) | Next Delivery: March 2023; Estimated Recovery: March 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 50 mEq/50 mL (1 mEq/mL) LifeShield® ABBOJECT® Glass Syringe (8.4% Concentration) (NDC 0409-6637-14) | Next Delivery: March 2023; Estimated Recovery: September 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 2.5 mEq/5 mL (0.5 mEq/mL) Fliptop Vial (4.2% Concentration) (NDC 0409-5555-02) | Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023 | Demand increase for the drug | |
| 2.5 mEq/5 mL (0.5 mEq/mL) Fliptop Vial Novaplus® (4.2% Concentration) (NDC 0409-5555-01) | Next Delivery: May 2023; Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 44.6 mEq/50 mL (0.9 mEq/mL) LifeShield™ ABBOJECT™ Glass Syringe (7.5% concentration) (NDC 0409-4916-14) | Next Delivery and Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 50 mEq/50 mL (1 mEq/mL) Single Dose Glass Fliptop Vial (8.4% concentration) (NDC 0409-6625-14) (old NDC 0409-6625-02) | Limited Supply Available. Next Delivery: March 2023; Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 50 mEq/50 mL (1 mEq/mL) Single Dose Vial Novaplus® (8.4% concentration) (NDC 0409-6625-35) | Next Delivery: April 2023; Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| Pediatric 10 mEq/10 mL (1 mEq/mL) LifeShield® ABBOJECT® Glass Syringe (8.4% Concentration) (NDC 0409-4900-14) | Next Delivery and Estimated Recovery: March 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |